Collaborating for a Cure: Max Gosling
Former Cure Cancer Chairman, Max Gosling, shares with us his reason for being part of The Collaboration.
The Collaboration program is Cure Cancer’s exclusive alliance of like-minded philanthropists who invest a minimum annual donation of $1,000 to support the brightest early-career cancer researchers. Regular donations provide a crucial level of support to cancer research, as it gives the ability to predict revenue, plan strategically and fund the best research throughout the year.
Members work in partnership with other dedicated individuals who are passionate about supporting ground-breaking, innovative ideas in the shared belief that this is the key to curing cancer.
Hear from Max Gosling about why he continues to support innovative cancer research through The Collaboration.
Max Gosling
Max’s Story
With a career spanning over 30 years and living in numerous cities such as Sydney, London and Tokyo, Max Gosling has seen the different ways that businesses can give back to the community.
As a former Chairman for multiple organisations, including Cure Cancer from 2006 to 2016, his philosophy as a businessman (and as a grandfather) is that ‘the less fortunate in society should be supported. We should be expected to make a contribution, to help.’
During his career, Max remained committed to introducing charities to businesses for corporate support. Since retiring, he has made a personal pledge to support several different charities financially, ‘I regard this support as part of my responsibility in society.’ His introduction to Cure Cancer in the 1980s came through the suggestion of a close friend, beginning a lifelong association to a charity specialising in a topic close to his heart: cancer.
‘I had prostate cancer about 14 years ago and had to have a radical robotic prostatectomy. To date, there has no been recurrence,’ he says.
‘My mother also died from pancreatic cancer, a form of cancer with a low recovery rate. What’s changed in cancer research since I was kid is the tremendous increase in the survival rate across so many cancer types. People recover today from aspects of many cancers that would have been a death sentence 30 years ago.’
For Max, funding is the obvious and only way for research to continue. ‘I know that research is vital to improving the recovery rate of cancer. The Government cannot fund to the level needed and we need more people committed to this research sector. I wish more people knew about the talented alumni of Cure Cancer and the astounding successes they have achieved.’
“Cancer research has a history of success. We need to reinforce the importance of continuing funding research because every dollar makes a difference. ”
Nearly forty years on, Max remains committed to supporting Cure Cancer and its innovative researchers for numerous reasons. ‘Cure Cancer focuses on all cancer types, not just one and their grant recipients are able to experience a high-calibre of scientific collaboration,’ he says. ‘I would like to help fund medical research and make cancer a manageable disease, with a higher recovery rate for all cancers. It’s important to me to support the new ideas of young cancer researchers at the beginning of their research careers.’
Working Together
Thank you to Max for sharing his story and giving us an insight into why being a part of Cure Cancer’s Collaboration is so important to him.
Join The Collaboration today by investing a minimum annual donation of $1,000 to support innovative cancer researchers. Together, let’s help us in our mission to make this the generation to die from cancer.